Prenatal-onset GBS Disease Recognition Month

Prenatal-onset GBS Disease Recognition Month is observed throughout October to raise awareness of prenatal-onset group B Streptococcus (GBS) disease and the serious health risks it can pose to newborns. The observance highlights the importance of understanding GBS, recognizing potential concerns during pregnancy, and encouraging informed conversations between expectant parents and healthcare professionals.

Throughout the month, families, medical providers, and communities are invited to learn more about prevention, screening, and early recognition of GBS-related illness. By sharing reliable information and supporting open communication during prenatal care, Prenatal-onset GBS Disease Recognition Month helps promote healthier pregnancies, safer births, and stronger starts for babies.

Prenatal-onset GBS Disease Recognition Month is observed throughout October to increase awareness of disease caused by group B Streptococcus (GBS), a bacterium that may be carried naturally in the digestive and genital tracts. Although GBS colonization is often harmless for adults, transmission from a pregnant person to an infant can lead to serious infection, including sepsis, pneumonia, or meningitis. The observance places particular emphasis on infections that begin before or around birth and on the importance of informed prenatal care. Public holiday references list October as the month of observance, while detailed accounts of a single founding organization or inaugural proclamation are not consistently documented. (See: [National Today](https://nationaltoday.com/prenatal-onset-gbs-disease-recognition-month/).)

The observance reflects the broader medical history of recognizing GBS as a major cause of newborn illness. During the 1970s and 1980s, research increasingly established that infants could acquire GBS from the mother during labor or delivery and that early-onset disease could progress rapidly. In the United States, the Centers for Disease Control and Prevention issued prevention recommendations in 1996, followed by national guidance favoring universal prenatal screening in 2002. These developments helped shift prevention from relying primarily on clinical risk factors to identifying maternal GBS carriage late in pregnancy and offering intravenous antibiotics during labor when appropriate.

Knowledge and clinical guidance continued to develop. Updated recommendations in 2010 brought together screening, laboratory testing, obstetric care, and newborn-management practices, while later guidance from professional medical organizations refined testing and treatment considerations. These changes have made GBS screening a familiar part of prenatal care in many health systems, but they have not eliminated the need for awareness: screening results can change, records may be unavailable, labor may occur before testing, and infants can occasionally become ill despite preventive measures. Recognition efforts therefore encourage communication among patients, families, obstetric professionals, midwives, pediatricians, and hospitals.

Culturally, the October observance gives families affected by GBS disease a setting in which to share experiences and advocate for clearer education, accessible prenatal testing, and rapid recognition of symptoms in newborns. It also honors the contributions of researchers and clinicians who established effective prevention strategies while emphasizing that awareness should be compassionate rather than stigmatizing. By spanning the whole month, Prenatal-onset GBS Disease Recognition Month connects personal stories with the longer history of maternal-fetal and newborn medicine and reminds communities that timely information and coordinated care can reduce the consequences of a potentially serious infection.